LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Clinical trial NCT02131155 · TERMINATED
Trial details
- NCT number
- NCT02131155
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-17
- Primary completion
- 2016-08-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.